Veeva Commercial Summit: Increased investment in medical affairs by pharma companies

Clinical Trials Arena November 20, 2024
Phalguni Deswal

Veeva’s VP of global medical, Christoph Bug, emphasises the importance of scientific exchange between clinical experts and pharmaceutical companies.

Pharmaceutical companies are always looking to increase the efficiency of clinical trials, and now many of these companies are looking at medical affairs team to improve these operations, according to Veeva’s VP of global medical, Christoph Bug.

In an interview at the 2024 Veeva Commercial Summit taking place from 19-21 November in Madrid, Bug noted that the medical affairs team can help improve trial efficiency in a variety of ways such as new investigators and trial sites, help improve trial communications and/or identify patient recruitment challenges.

Low accrual remain the leading cause of trial termination, as per a GlobalData analysis that...

Today's Sponsors

Today's Sponsor